Clinical Trial Update: The Effect of Oral Baclofen and Botulinum Toxin Treatments in Hemiplegic Spasticity on the Nociceptive Flexor Reflex [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of oral baclofen and botulinum toxin on nociceptive flexor reflex in hemiplegic spasticity due to stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spastic Hemiplegia
• Stroke Sequelae

Drugs mentioned

• BACLOFEN (Baclofen)
• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Mustafa Kemal University | Conditions: Stroke Sequelae, Spastic Hemiplegia | Phase 4 | Status: COMPLETED